Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

Millions of Brits are now eligible for the appetite-suppressing jabs which can come with unpleasant side effects - but NHS rationing means only a tiny fraction will be prescribed them ...

Some patients have experienced critical shifts in blood sodium levels.

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are "concerned that the current regulations allow some patients to ...

Health experts have issued a new warning about the online sale of weight-loss jabs.The focus of these fresh updates were the ...

Weight-loss jabs, known as GLP-1 receptor agonists, work by reducing food cravings. The NPA has previously urged patients to ...

Weight loss jabs, known as GLP-1 receptor agonists, work by reducing food cravings. In October, the MHRA told health ...

Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...

There are precedents for a hybrid NHS-private model of healthcare. Ten years ago, a new drug treatment arrived that could ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common ...

Skinny jabs have taken the world by storm over the past few years, but a lot of people keep their decision to use them a ...